• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一级护理单元中乳腺影像报告和数据系统(BIRADS)0类患者的重新分类]

[BIRADS 0 patient reclassification in a first-level of care unit].

作者信息

Garza-Rugerio Graciela, Muñoz-Ahuatzin Noe, León-Vázquez María de la Luz, Maycotte-González Paola, Seefoó-Jarquín Patricia

机构信息

Instituto Mexicano del Seguro Social, Hospital General de Zona con Unidad de Medicina Familiar No. 2, Servicio de Medicina Familiar. Apizaco, Tlaxcala, México.

Instituto Mexicano del Seguro Social, Órgano de Operación Administrativa Desconcentrada Tlaxcala, Coordinación de Investigación en Salud. Tlaxcala, Tlaxcala, México.

出版信息

Rev Med Inst Mex Seguro Soc. 2024 Jan 8;62(1):1-7. doi: 10.5281/zenodo.10278086.

DOI:10.5281/zenodo.10278086
PMID:39106348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12088694/
Abstract

BACKGROUND

In Mexico and the world, breast cancer is the cancer type with the highest incidence and mortality for women. Its incidence has increased due to a higher life expectancy and a higher exposure to risk factors. Screening is done by mammography using the BIRADS (Breast Imaging Reporting and Data System) system, the standard for mammography screening report which classifies lesions assigning recommendations for patient follow-up. The system goes from 0 (not conclusive) to 6 (demonstrated malignancy), being of interest for this study the BIRADS 0 category.

OBJECTIVE

To describe patients classified as BIRADS 0 by mammography and their reclassification in a first-level hospital during 2021.

MATERIAL AND METHODS

Retrospective, descriptive, cross-sectional, observational study. Women over 40 years with a BIRADS 0 result were studied. The following databases were used: Institutional Cancer Registry, Family Medicine Information System, Electronic Clinical File, and the mammography and patient list from preventive medicine.

RESULTS

Reclassification by ultrasound (US) was achieved in 100% of patients, in all of the BIRADS US categories. In 3.8% of BIRADS 0 patients, ductal adenocarcinoma was found and confirmed by histological testing.

CONCLUSION

All of the reassessed lesions with US were adequately reclassified.

摘要

背景

在墨西哥乃至全球,乳腺癌是女性中发病率和死亡率最高的癌症类型。由于预期寿命延长和风险因素暴露增加,其发病率有所上升。筛查通过使用乳腺影像报告和数据系统(BIRADS)的乳房X线摄影进行,该系统是乳房X线摄影筛查报告的标准,对病变进行分类并为患者随访提供建议。该系统从0(不确定)到6(确诊为恶性),本研究关注的是BIRADS 0类别。

目的

描述2021年在一家一级医院中被乳房X线摄影分类为BIRADS 0的患者及其重新分类情况。

材料与方法

回顾性、描述性、横断面观察性研究。研究对象为40岁以上BIRADS 0结果的女性。使用了以下数据库:机构癌症登记处、家庭医学信息系统、电子临床档案以及预防医学的乳房X线摄影和患者名单。

结果

所有患者均通过超声(US)实现了重新分类,涵盖所有BIRADS超声类别。在3.8%的BIRADS 0患者中发现了导管腺癌,并经组织学检测确诊。

结论

所有经超声重新评估的病变均得到了充分的重新分类。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0291/12088694/dc97de96031a/04435117-62-1-e5252-c003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0291/12088694/00b6e03ec21d/04435117-62-1-e5252-c001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0291/12088694/e320b5ac340a/04435117-62-1-e5252-c002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0291/12088694/dc97de96031a/04435117-62-1-e5252-c003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0291/12088694/00b6e03ec21d/04435117-62-1-e5252-c001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0291/12088694/e320b5ac340a/04435117-62-1-e5252-c002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0291/12088694/dc97de96031a/04435117-62-1-e5252-c003.jpg

相似文献

1
[BIRADS 0 patient reclassification in a first-level of care unit].[一级护理单元中乳腺影像报告和数据系统(BIRADS)0类患者的重新分类]
Rev Med Inst Mex Seguro Soc. 2024 Jan 8;62(1):1-7. doi: 10.5281/zenodo.10278086.
2
[Mammographic and ultrasonographic BIRADS classification and its correlation with histopathologic findings].[乳腺钼靶和超声检查的BIRADS分类及其与组织病理学结果的相关性]
Ginecol Obstet Mex. 2016 Mar;84(3):136-42.
3
Improved Performance of Adjunctive Ultrasonography After Mammography Screening for Breast Cancer Among Chinese Females.乳腺 X 线摄影筛查乳腺癌中附加超声检查的表现改善。
Clin Breast Cancer. 2018 Jun;18(3):e353-e361. doi: 10.1016/j.clbc.2017.07.014. Epub 2017 Aug 15.
4
Knowledge related to breast cancer screening programs by physicians in Brazil.巴西医生对乳腺癌筛查项目的认知。
Einstein (Sao Paulo). 2024 Oct 14;22:eAO0760. doi: 10.31744/einstein_journal/2024AO0760. eCollection 2024.
5
Accuracy of clinical diagnosis, mammography and ultrasonography in preoperative assessment of breast cancer.临床诊断、乳腺X线摄影及超声检查在乳腺癌术前评估中的准确性。
Ghana Med J. 2018 Sep;52(3):133-139. doi: 10.4314/gmj.v52i3.5.
6
Pathological and radiological assessment of benign breast lesions with BIRADS IVc/V subtypes. should we repeat the biopsy?对具有BIRADS IVc/V亚型的乳腺良性病变进行病理和放射学评估。我们是否应该重复活检?
BMC Womens Health. 2025 Feb 3;25(1):47. doi: 10.1186/s12905-025-03569-7.
7
A Retrospective Analysis of Diagnostic Breast Imaging Outcomes in Young Women at a Tertiary Care Center.回顾性分析三级保健中心年轻女性的乳腺影像学诊断结果。
Curr Oncol. 2024 Jul 6;31(7):3939-3948. doi: 10.3390/curroncol31070291.
8
Audit of mammography requests in Abakaliki, South-East Nigeria.尼日利亚东南部阿巴卡利基乳房X光检查申请审计
World J Surg Oncol. 2017 Mar 7;15(1):56. doi: 10.1186/s12957-017-1122-7.
9
Utility of routine use of breast ultrasound following contrast-enhanced spectral mammography.对比增强光谱乳腺摄影术后常规使用乳腺超声的效用。
Clin Radiol. 2018 Oct;73(10):908.e11-908.e16. doi: 10.1016/j.crad.2018.05.031. Epub 2018 Jul 2.
10
Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.乳腺 X 线筛查和超声筛查检出 BI-RADS 4 类病变的评估:磁共振成像的应用。
Radiology. 2015 Feb;274(2):343-51. doi: 10.1148/radiol.14140645. Epub 2014 Sep 29.

本文引用的文献

1
Overdiagnosis Due to Screening Mammography for Breast Cancer among Women Aged 40 Years and Over: A Systematic Review and Meta-Analysis.40岁及以上女性乳腺癌筛查钼靶摄影导致的过度诊断:一项系统评价和荟萃分析
J Pers Med. 2023 Mar 14;13(3):523. doi: 10.3390/jpm13030523.
2
Mammographic Breast Density: Current Assessment Methods, Clinical Implications, and Future Directions.乳腺钼靶密度:当前评估方法、临床意义及未来方向。
Semin Ultrasound CT MR. 2023 Feb;44(1):35-45. doi: 10.1053/j.sult.2022.11.001. Epub 2022 Nov 4.
3
Diagnostic performance of mammography and ultrasound in breast cancer: a systematic review and meta-analysis.
乳腺 X 线摄影与超声检查在乳腺癌诊断中的性能:系统评价和荟萃分析。
J Ultrasound. 2023 Jun;26(2):355-367. doi: 10.1007/s40477-022-00755-3. Epub 2023 Jan 25.
4
Mammographic breast density and the risk of breast cancer: A systematic review and meta-analysis.乳腺钼靶密度与乳腺癌风险:系统评价和荟萃分析。
Breast. 2022 Dec;66:62-68. doi: 10.1016/j.breast.2022.09.007. Epub 2022 Sep 26.
5
Current and future burden of breast cancer: Global statistics for 2020 and 2040.乳腺癌的现状和未来负担:2020 年和 2040 年全球统计数据。
Breast. 2022 Dec;66:15-23. doi: 10.1016/j.breast.2022.08.010. Epub 2022 Sep 2.
6
Reducing Disparities in Timely Follow-Up After Abnormal Findings on Screening Mammography.减少乳腺钼靶筛查异常结果后及时随访中的差异。
J Am Coll Radiol. 2022 Nov;19(11):1269-1270. doi: 10.1016/j.jacr.2022.08.003. Epub 2022 Aug 17.
7
Global guidelines for breast cancer screening: A systematic review.全球乳腺癌筛查指南:系统评价。
Breast. 2022 Aug;64:85-99. doi: 10.1016/j.breast.2022.04.003. Epub 2022 Apr 19.
8
Impact of childbirth history on dense breast in mammographic screening: a cross-sectional study.生育史对乳腺钼靶筛查致密型乳腺的影响:一项横断面研究。
BMC Womens Health. 2022 May 26;22(1):194. doi: 10.1186/s12905-022-01772-4.
9
Breast cancer screening in low and middle-income countries.在中低收入国家进行乳腺癌筛查。
Best Pract Res Clin Obstet Gynaecol. 2022 Sep;83:15-23. doi: 10.1016/j.bpobgyn.2022.03.018. Epub 2022 Apr 20.
10
Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures.全球乳腺癌发病率上升:风险因素和预防措施。
Biomed Res Int. 2022 Apr 18;2022:9605439. doi: 10.1155/2022/9605439. eCollection 2022.